NCT03985319View on ClinicalTrials.gov

Clinical Trial to Assess the PK/PD of YYD601 20mg After Oral Administration if Healthy Adult Subjects (Phase1)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 8, 2019

Primary Completion Date

February 7, 2020

Study Completion Date

March 20, 2020

Conditions

GERD

Interventions

DRUG

YYD601 20mg

Esomeprazole IR 10mg + Esomeprazole SR 10mg (Expected efficacy and effects: GERD)

DRUG

Nexium tab 20mg

Esomeprazole magnesium trihydrate 22.3mg Effecacy and Effects: GERD and Antibiotics combined therapy to eradicate the Helicobacter pylori

Trial Locations (1)

Unknown

Kyungpook national university hospital, Daegu

All Listed Sponsors

lead

Yooyoung Pharmaceutical Co., Ltd.

INDUSTRY

NCT03985319 - Clinical Trial to Assess the PK/PD of YYD601 20mg After Oral Administration if Healthy Adult Subjects (Phase1) | Biotech Hunter | Biotech Hunter